LXRX vs MGM · rev $21.8M vs P/E 64, rev $4.45B
Lexicon Pharmaceuticals Inc (LXRX) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
LXRX currently screens at market cap $327.2M. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the LXRX and MGM stock pages for the full models.
Not investment advice.